Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hepatitis

  Free Subscription


Articles published in J Med Virol

Retrieve available abstracts of 165 articles:
HTML format
Text format



Single Articles


    March 2017
  1. HIRAMATSU K, Matsuda H, Nemoto T, Nosaka T, et al
    Identification of novel variants in HLA class II region related to HLA DPB1 expression and disease progression in patients with chronic hepatitis C.
    J Med Virol. 2017 Mar 22. doi: 10.1002/jmv.24814.
    PubMed     Text format     Abstract available


  2. EIJSVOOGEL NB, Hollegien MI, Bok LA, Derksen-Lubsen A, et al
    Declining antibody levels after hepatitis B vaccination in Down syndrome: a need for booster vaccination?
    J Med Virol. 2017 Mar 21. doi: 10.1002/jmv.24813.
    PubMed     Text format     Abstract available


  3. JONES M, Cunningham ME, Wing P, DeSilva S, et al
    SB 9200, a novel agonist of innate immunity, shows potent antiviral activity against resistant HCV variants.
    J Med Virol. 2017 Mar 17. doi: 10.1002/jmv.24809.
    PubMed     Text format     Abstract available


    February 2017
  4. YANG Y, Du D, Jin L, Tian Z, et al
    A molecular epidemiology study investigating familial clustering of hepatitis B virus infection in families with unfavorable prognoses in Northwest China.
    J Med Virol. 2017 Feb 15. doi: 10.1002/jmv.24783.
    PubMed     Text format     Abstract available


  5. FU X, Chen J, Chen H, Lin J, et al
    Mutation in the S gene of hepatitis B virus and anti-HBs subtype-nonspecificity contributed to the coexistence of HBsAg and anti-HBs in patients with chronic hepatitis B virus infection.
    J Med Virol. 2017 Feb 15. doi: 10.1002/jmv.24782.
    PubMed     Text format     Abstract available


  6. FLORES GL, Cruz HM, Marques VA, Villela-Nogueira CA, et al
    Performance of anti-HCV testing in dried blood spots and saliva according to HIV status.
    J Med Virol. 2017 Feb 6. doi: 10.1002/jmv.24777.
    PubMed     Text format     Abstract available


  7. WATANABE T, Tokumoto Y, Joko K, Michitaka K, et al
    Predictors of treatment efficacy and ALT non-normalization with sofosbuvir/ribavirin therapy for patients with hepatitis C virus genotype 2.
    J Med Virol. 2017 Feb 6. doi: 10.1002/jmv.24776.
    PubMed     Text format     Abstract available


    January 2017
  8. HUNDIE GB, Raj VS, Gebre Michael D, Haagmans BL, et al
    Seroepidemiology of hepatitis B and C virus infections among blood donors in Ethiopia.
    J Med Virol. 2017 Jan 25. doi: 10.1002/jmv.24770.
    PubMed     Text format     Abstract available


  9. AKUTA N, Sezaki H, Suzuki F, Fujiyama S, et al
    Ledipasvir plus sofosbuvir as salvage therapy for HCV genotype 1 failures to prior NS5A inhibitors regimens.
    J Med Virol. 2017 Jan 12. doi: 10.1002/jmv.24767.
    PubMed     Text format     Abstract available


  10. GRANDAL M, Pernas B, Marino A, Alvarez H, et al
    Characterization of chronic HCV infection in Northwest Spain: Impact of the treatment strategic plan of the Spanish National Health Service on HCV cure.
    J Med Virol. 2017 Jan 12. doi: 10.1002/jmv.24766.
    PubMed     Text format     Abstract available


    December 2016
  11. MURAKAWA M, Asahina Y, Kawai-Kitahata F, Nakagawa M, et al
    Hepatic IFNL4 expression is associated with non-response to interferon-based therapy through the regulation of basal interferon-stimulated gene expression in chronic hepatitis C patients.
    J Med Virol. 2016 Dec 30. doi: 10.1002/jmv.24763.
    PubMed     Text format     Abstract available


  12. LIU X, Zhang L, Wu XP, Zhu XL, et al
    Polymorphisms in IRG1 gene associated with immune responses to hepatitis B vaccination in a Chinese Han population and function to restrain the HBV life cycle.
    J Med Virol. 2016 Dec 22. doi: 10.1002/jmv.24756.
    PubMed     Text format     Abstract available


  13. WANG L, Chen W, WenXi, Feng J, et al
    The utility of enzyme-linked immunosorbent assays to test core antigen in the diagnosis and antiviral therapy management of hepatitis C virus infections.
    J Med Virol. 2016 Dec 13. doi: 10.1002/jmv.24754.
    PubMed     Text format     Abstract available


  14. ZHAO N, Liu J, Sun D
    Detection of HCV genotypes 1b and 2a by a reverse transcription loop-mediated isothermal amplification assay.
    J Med Virol. 2016 Dec 9. doi: 10.1002/jmv.24747.
    PubMed     Text format     Abstract available


  15. MADEDDU G, Ortu S, Garrucciu G, Maida I, et al
    DNMT1 modulation in Chronic Hepatitis B patients and hypothetic influence on Mitochondrial DNA methylation status during long-term Nucleo(t)side Analogues Therapy.
    J Med Virol. 2016 Dec 6. doi: 10.1002/jmv.24742.
    PubMed     Text format     Abstract available


  16. KODANI M, Ahmed N, Tejada-Strop A, Poe A, et al
    Variability in the performance characteristics of IgG anti-HEV assays and its impact on reliability of seroprevalence rates of hepatitis E.
    J Med Virol. 2016 Dec 6. doi: 10.1002/jmv.24741.
    PubMed     Text format     Abstract available


  17. MIURA M, Inoue J, Tsuruoka M, Nishizawa T, et al
    Full-length genomic sequence analysis of new subtype 3k hepatitis E virus isolates with 99.97% nucleotide identity obtained from two consecutive acute hepatitis patients in a city in northeast Japan.
    J Med Virol. 2016 Dec 6. doi: 10.1002/jmv.24743.
    PubMed     Text format     Abstract available


  18. NGOC NB, Okuno Y, Ajiro M, Iida K, et al
    Retinoid derivative Tp80 exhibits anti-hepatitis C virus activity through restoration of GI-GPx expression.
    J Med Virol. 2016 Dec 6. doi: 10.1002/jmv.24739.
    PubMed     Text format     Abstract available


    November 2016
  19. ELFIKY AA, Mahdy SM, Elshemey WM
    Quantitative structure-activity relationship and molecular docking revealed a potency of anti-hepatitis C virus drugs against human corona viruses.
    J Med Virol. 2016 Nov 19. doi: 10.1002/jmv.24736.
    PubMed     Text format     Abstract available


  20. THURNHEER MC, Edwards R, Schulz TR, Yuen L, et al
    Genotypic profiles of Hepatitis B in African immigrants and their clinical relevance.
    J Med Virol. 2016 Nov 11. doi: 10.1002/jmv.24732.
    PubMed     Text format     Abstract available


  21. SALEMI JL, Spooner KK, Mejia de Grubb MC, Aggarwal A, et al
    National trends of hepatitis B and C during pregnancy across sociodemographic, behavioral, and clinical factors, United States, 1998-2011.
    J Med Virol. 2016 Nov 2. doi: 10.1002/jmv.24725.
    PubMed     Text format     Abstract available


  22. BODEAU S, Lemouel JP, Diouf M, Duverlie G, et al
    Hemoglobin during ribavirin-based HCV therapy is closely related to circulating levels of DHEA.
    J Med Virol. 2016 Nov 2. doi: 10.1002/jmv.24726.
    PubMed     Text format     Abstract available


    October 2016
  23. KATAKI K, Borthakur P, Kumari N, Deka M, et al
    Association of mRNA expression of Toll like receptor 2 and 3 with hepatitis B viral load in chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    J Med Virol. 2016 Oct 21. doi: 10.1002/jmv.24719.
    PubMed     Text format     Abstract available


  24. KANG SH, Kang K, Yeon JE, Lee YS, et al
    Antiviral response is not sustained after cessation of lamivudine treatment in chronic hepatitis B patients: A 10-year follow-up study.
    J Med Virol. 2016 Oct 21. doi: 10.1002/jmv.24715.
    PubMed     Text format     Abstract available


  25. HUMAYED SM, El-Mekki AA, Mahfouz AA
    Hepatitis C virus infection in south-western Saudi Arabia: Are we still in the plateau phase?
    J Med Virol. 2016 Oct 13. doi: 10.1002/jmv.24712.
    PubMed     Text format     Abstract available


  26. KUMAR R, Testoni B, Fresquet J, Lim TK, et al
    Development of hepatocellular carcinoma in chronic hepatitis B patients with advanced fibrosis is independent of viral genotype.
    J Med Virol. 2016 Oct 6. doi: 10.1002/jmv.24707.
    PubMed     Text format     Abstract available


  27. CLAUS M, Kimbel R, Schone K, Letzel S, et al
    Seroepidemiology of hepatitis A and B and vaccination status in staff at German schools for the handicapped.
    J Med Virol. 2016 Oct 3. doi: 10.1002/jmv.24699.
    PubMed     Text format     Abstract available


    September 2016
  28. KANG YH, Cong W, Zhang XY, Wang CF, et al
    Hepatitis E virus seroprevalence among farmers, veterinarians and control subjects in Jilin province, Shandong province and Inner Mongolia Autonomous Region, China.
    J Med Virol. 2016 Sep 24. doi: 10.1002/jmv.24693.
    PubMed     Text format     Abstract available


  29. TSUKUDA Y, Suda G, Tsunematsu S, Ito J, et al
    Anti-adipogenic and antiviral effects of L-carnitine on hepatitis C virus infection.
    J Med Virol. 2016 Sep 24. doi: 10.1002/jmv.24692.
    PubMed     Text format     Abstract available


  30. ROUABHIA S, Chaabna K
    Hepatitis C infection in eastern Algeria: Between statistics and reality.
    J Med Virol. 2016 Sep 14. doi: 10.1002/jmv.24686.
    PubMed     Text format     Abstract available


  31. ELFIKY AA
    Zika viral polymerase inhibition using anti-HCV drugs both in market and under clinical trials.
    J Med Virol. 2016 Sep 7. doi: 10.1002/jmv.24678.
    PubMed     Text format     Abstract available


  32. NAKAMURA Y, Imamura M, Kawakami Y, Teraoka Y, et al
    Efficacy and safety of daclatasvir plus asunaprevir therapy for chronic hepatitis C patients with renal dysfunction.
    J Med Virol. 2016 Sep 7. doi: 10.1002/jmv.24679.
    PubMed     Text format     Abstract available


  33. EL-EKIABY NM, Mekky RY, Riad SE, Elhelw DS, et al
    miR-148a and miR-30a limit HCV-dependent suppression of the lipid droplet protein, ADRP, in HCV infected cell models.
    J Med Virol. 2016 Sep 3. doi: 10.1002/jmv.24677.
    PubMed     Text format     Abstract available


    August 2016
  34. CELLA E, Ceccarelli G, Vita S, Lai A, et al
    First epidemiological and phylogenetic analysis of hepatitis B virus infection in migrants from Mali.
    J Med Virol. 2016 Aug 30. doi: 10.1002/jmv.24671.
    PubMed     Text format     Abstract available


  35. WU S, Yan P, Yang T, Wang Z, et al
    Epidemiological profile and risk factors of HIV and HBV/HCV co-infection in Fujian Province, southeastern China.
    J Med Virol. 2016 Aug 23. doi: 10.1002/jmv.24666.
    PubMed     Text format     Abstract available


  36. MARCIANO S, Haddad L, Plazzotta F, Mauro E, et al
    Implementation of the ECHO(R) telementoring model for the treatment of patients with hepatitis C.
    J Med Virol. 2016 Aug 23. doi: 10.1002/jmv.24668.
    PubMed     Text format     Abstract available


  37. KOBAYASHI M, Suzuki F, Fujiyama S, Kawamura Y, et al
    Sustained virologic response by direct anti-viral agents reduces the incidence of hepatocellular carcinoma in patients with HCV infection.
    J Med Virol. 2016 Aug 17. doi: 10.1002/jmv.24663.
    PubMed     Text format     Abstract available


  38. HAYES CN, Chayama K
    Interferon stimulated genes and innate immune activation following infection with hepatitis B and C viruses.
    J Med Virol. 2016 Aug 10. doi: 10.1002/jmv.24659.
    PubMed     Text format     Abstract available


  39. SONG G, Yang R, Rao H, Feng B, et al
    Serum HBV core related antigen is a good predictor for spontaneous HBeAg seroconversion in chronic hepatitis B patients.
    J Med Virol. 2016 Aug 9. doi: 10.1002/jmv.24657.
    PubMed     Text format     Abstract available


  40. YONG HAO G, Da Xing F, Jin X, Xiu Hong F, et al
    The prevalence of hepatitis B infection in central China: An adult population-based serological survey of a large sample size.
    J Med Virol. 2016 Aug 9. doi: 10.1002/jmv.24649.
    PubMed     Text format     Abstract available


  41. ALBUQUERQUE IC, Sousa MT, Santos MD, Nunes JD, et al
    Mutation in the a-determinant of the S gene of the hepatitis B virus associated with concomitant HBsAg and anti-HBs in a population in northeastern Brazil.
    J Med Virol. 2016 Aug 2. doi: 10.1002/jmv.24653.
    PubMed     Text format     Abstract available


  42. YILMAZ B
    Fulminant hepatitis B as a result of reactivation in hematologic patient after rituximab therapy.
    J Med Virol. 2016;88:1289-90.
    PubMed     Text format    


    July 2016
  43. DE PASCHALE M, Manco MT, Belvisi L, Cagnin D, et al
    Evaluation of LIAISON(R) XL system for HBsAg, and anti-HCV and anti-HIV/Ag p24.
    J Med Virol. 2016 Jul 28. doi: 10.1002/jmv.24648.
    PubMed     Text format     Abstract available


  44. TSUNEMATSU S, Suda G, Yamasaki K, Kimura M, et al
    Hepatitis B virus X protein impairs alpha-interferon signaling via up-regulation of suppressor of cytokine signaling 3 and protein phosphatase 2A.
    J Med Virol. 2016 Jul 26. doi: 10.1002/jmv.24643.
    PubMed     Text format     Abstract available


  45. REBBANI K, Ababou M, Nadifi S, Kandil M, et al
    Myxovirus resistance 1 gene polymorphisms and outcomes of viral hepatitis B and C infections in Moroccan patients.
    J Med Virol. 2016 Jul 26. doi: 10.1002/jmv.24642.
    PubMed     Text format     Abstract available


  46. BAUDI I, Iijima S, Chin'ombe N, Mtapuri-Zinyowera S, et al
    Molecular epidemiology of co-infection with hepatitis B virus and human immunodeficiency virus (HIV) among adult patients in Harare, Zimbabwe.
    J Med Virol. 2016 Jul 26. doi: 10.1002/jmv.24641.
    PubMed     Text format     Abstract available


  47. HOULDSWORTH A
    Exploring the possibility of arthropod transmission of HCV.
    J Med Virol. 2016 Jul 22. doi: 10.1002/jmv.24638.
    PubMed     Text format     Abstract available


  48. MORISCO F, Loperto I, Stroffolini T, Lombardo FL, et al
    Prevalence and risk factors of HCV infection in a metropolitan area in Southern Italy: Tail of a cohort infected in past decades.
    J Med Virol. 2016 Jul 19. doi: 10.1002/jmv.24635.
    PubMed     Text format     Abstract available


  49. SADEGHI A, Shirvani-Dastgerdi E, Tacke F, Yagmur E, et al
    HBsAg mutations related to occult hepatitis B virus infection in HIV-positive patients result in a reduced secretion and conformational changes of HBsAg.
    J Med Virol. 2016 Jul 6. doi: 10.1002/jmv.24623.
    PubMed     Text format     Abstract available


  50. OLIVEIRA MP, Lemes PS, Matos MA, Del-Rios NH, et al
    Overt and occult hepatitis B virus infection among treatment-naive HIV-infected patients in Brazil.
    J Med Virol. 2016;88:1222-9.
    PubMed     Text format     Abstract available


    June 2016
  51. LEI JH, Tian Y, Luo HY, Chen Z, et al
    Guillain-Barre syndrome following acute co-super-infection of hepatitis E virus and cytomegalovirus in a chronic hepatitis B virus carrier.
    J Med Virol. 2016 Jun 30. doi: 10.1002/jmv.24620.
    PubMed     Text format     Abstract available


  52. AKUTA N, Sezaki H, Suzuki F, Fujiyama S, et al
    Retreatment efficacy and predictors of ledipasvir plus sofosbuvir to HCV genotype 1 in Japan.
    J Med Virol. 2016 Jun 30. doi: 10.1002/jmv.24617.
    PubMed     Text format     Abstract available


  53. IKEDA H, Watanabe T, Okuse C, Matsumoto N, et al
    Impact of resistance-associated variant dominancy on treatment in patients with HCV genotype 1b receiving daclatasvir/asunaprevir.
    J Med Virol. 2016 Jun 22. doi: 10.1002/jmv.24608.
    PubMed     Text format     Abstract available


  54. LIAO H, Li X, Liu Y, Xu Z, et al
    Intergenotype recombinant analysis of full-length hepatitis B virus genomes from 516 Chinese patients with different illness categories.
    J Med Virol. 2016 Jun 22. doi: 10.1002/jmv.24609.
    PubMed     Text format     Abstract available


  55. CHUAYPEN N, Sriprapun M, Praianantathavorn K, Payungporn S, et al
    Kinetics of serum HBsAg and intrahepatic cccDNA during pegylated interferon therapy in patients with HBeAg-positive and HBeAg-negative chronic hepatitis B.
    J Med Virol. 2016 Jun 16. doi: 10.1002/jmv.24601.
    PubMed     Text format     Abstract available


  56. BEGHIN JC, Ruelle J, Sokal E, Bachy A, et al
    Effectiveness of the South African expanded program of immunization against hepatitis B in children infected with human immunodeficiency virus-1 living in a resource-limited setting of Kwazulu-Natal.
    J Med Virol. 2016 Jun 13. doi: 10.1002/jmv.24598.
    PubMed     Text format     Abstract available


  57. LIN JW, Chang ML, Hsu CW, Chen YC, et al
    Acute exacerbation of hepatitis C in hepatocellular carcinoma patients receiving chemotherapy.
    J Med Virol. 2016 Jun 8. doi: 10.1002/jmv.24595.
    PubMed     Text format     Abstract available


  58. AKUTA N, Sezaki H, Suzuki F, Kawamura Y, et al
    Favorable efficacy of daclatasvir plus asunaprevir in treatment of elderly Japanese patients infected with HCV genotype 1b aged 70 and older.
    J Med Virol. 2016 Jun 3. doi: 10.1002/jmv.24592.
    PubMed     Text format     Abstract available


  59. CHUNG A, Jin B, Han KH, Ahn SH, et al
    Cell culture-adaptive mutations of NS5A affect replication of hepatitis C virus differentially depending on the viral genotypes.
    J Med Virol. 2016 Jun 2. doi: 10.1002/jmv.24591.
    PubMed     Text format     Abstract available


  60. CANDOTTI D, Diarra B, Bisseye C, Tao I, et al
    Molecular characterization of hepatitis B virus in blood donors from Burkina Faso: prevalence of quasi-subgenotype A3, genotype E and mixed infections.
    J Med Virol. 2016 Jun 2. doi: 10.1002/jmv.24589.
    PubMed     Text format     Abstract available


  61. DIRCHWOLF M, Marciano S, Mauro E, Ruf A, et al
    Clinical epidemiology of acute hepatitis C in South America.
    J Med Virol. 2016 Jun 2. doi: 10.1002/jmv.24588.
    PubMed     Text format     Abstract available


    May 2016
  62. TAJIMA K, NaotoTakahashi, Ishizawa K, Murai K, et al
    High prevalence of diffuse large B-cell lymphoma in occult hepatitis B virus-infected patients in the Tohoku district in Eastern Japan.
    J Med Virol. 2016 May 24. doi: 10.1002/jmv.24584.
    PubMed     Text format     Abstract available


  63. ANDRIAMANDIMBY SF, Presti AL, Lai A, Olive MM, et al
    Genetic diversity of hepatitis B virus (HBV) in Madagascar.
    J Med Virol. 2016 May 16. doi: 10.1002/jmv.24576.
    PubMed     Text format     Abstract available


  64. HELAL GK, Gad MA, Abd-Ellah MF, Eid MS, et al
    Hydroxychloroquine augments early virological response to pegylated interferon plus ribavirin in genotype-4 chronic hepatitis C patients.
    J Med Virol. 2016 May 16. doi: 10.1002/jmv.24575.
    PubMed     Text format     Abstract available


  65. ALBERTI A, Lacoin L, Morais E, Lefevre C, et al
    A literature review of the distribution of hepatitis C virus genotypes across Europe.
    J Med Virol. 2016 May 12. doi: 10.1002/jmv.24573.
    PubMed     Text format     Abstract available


  66. BANG BR, Elmasry S, Saito T
    Organ system view of the hepatic innate immunity in HCV infection.
    J Med Virol. 2016 May 6. doi: 10.1002/jmv.24569.
    PubMed     Text format     Abstract available


  67. MISHRA S, Borkakoti J, Kumar S, Kar P, et al
    Role of HEV antigen detection in HEV related acute viral hepatitis and acute liver failure.
    J Med Virol. 2016 May 5. doi: 10.1002/jmv.24567.
    PubMed     Text format     Abstract available


  68. GUEYE SB, Diop-Ndiaye H, Lo G, Mintsa S, et al
    HBV carriage in children born from HIV-seropositive mothers in Senegal: The need of birth-dose HBV vaccination.
    J Med Virol. 2016;88:815-9.
    PubMed     Text format     Abstract available


    April 2016
  69. WANG LS, D'Souza LS, Jacobson IM
    Hepatitis C- A clinical review.
    J Med Virol. 2016 Apr 20. doi: 10.1002/jmv.24554.
    PubMed     Text format     Abstract available


  70. TSANKOVA GS, Kostadinova T, Todorova TT
    Seroprevalence of hepatitis B among pregnant women in Varna Region, Bulgaria.
    J Med Virol. 2016 Apr 6. doi: 10.1002/jmv.24543.
    PubMed     Text format     Abstract available


  71. LIU L, Wang L, Xia J, Zhang Y, et al
    Mix-breeding with HEV-infected swine induced inapparent HEV infection in SPF rabbits.
    J Med Virol. 2016;88:681-5.
    PubMed     Text format     Abstract available


  72. VARGAS JI, Jensen D, Sarmiento V, Peirano F, et al
    Presence of anti-HBc is associated to high rates of HBV resolved infection and low threshold for Occult HBV Infection in HIV patients with negative HBsAg in Chile.
    J Med Virol. 2016;88:639-46.
    PubMed     Text format     Abstract available


    March 2016
  73. SILVA MC, Silva CA, Machado GU, Atta A, et al
    HCV/HTLV coinfection: Does HTLV-1 interfere in the natural history of HCV-related diseases?
    J Med Virol. 2016 Mar 30. doi: 10.1002/jmv.24538.
    PubMed     Text format     Abstract available


  74. PEDERSEN J, Lundbo LF, Krarup H, Bukh J, et al
    Neutralizing antibodies in patients with chronic hepatitis C and correlation to liver cirrhosis and estimated duration of infection.
    J Med Virol. 2016 Mar 29. doi: 10.1002/jmv.24537.
    PubMed     Text format     Abstract available


  75. CHAIWONG S, Sistayanarain A
    Characterization of partial NS5B region among hepatitis C virus genotype 6 subtypes isolated from thai blood donors.
    J Med Virol. 2016 Mar 27. doi: 10.1002/jmv.24536.
    PubMed     Text format     Abstract available


  76. BOGLIONE L, Cariti G, Di Perri G, D'Avolio A, et al
    Sequential therapy with entecavir and pegylated interferon in a cohort of young patients affected by chronic hepatitis B.
    J Med Virol. 2016 Mar 27. doi: 10.1002/jmv.24534.
    PubMed     Text format     Abstract available


  77. TAHATA Y, Hiramatsu N, Oze T, Urabe A, et al
    The impact of ribavirin dosage in chronic hepatitis C patients treated with simeprevir, pegylated interferon plus ribavirin combination therapy.
    J Med Virol. 2016 Mar 18. doi: 10.1002/jmv.24528.
    PubMed     Text format     Abstract available


  78. COPPOLA N, Minichini C, Starace M, Sagnelli C, et al
    Clinical impact of the hepatitis C virus mutations in the era of directly acting antivirals.
    J Med Virol. 2016 Mar 18. doi: 10.1002/jmv.24527.
    PubMed     Text format     Abstract available


  79. EL-GHITANY EM, Farghaly AG, Abdel Wahab MM, Farag S, et al
    Towards a simple risk assessment screening tool for HCV infection in Egypt.
    J Med Virol. 2016 Mar 11. doi: 10.1002/jmv.24520.
    PubMed     Text format     Abstract available


  80. GUSATTI CS, Costi C, de Medeiros RM, Halon ML, et al
    Association between cytokine gene polymorphisms and outcome of hepatitis B virus infection in southern Brazil.
    J Med Virol. 2016 Mar 9. doi: 10.1002/jmv.24518.
    PubMed     Text format     Abstract available


  81. AN J, Shim JH, Kim SO, Choi J, et al
    Comprehensive outcomes of on- and off-antiviral prophylaxis in hepatitis B patients undergoing cancer chemotherapy: A competing risks analysis.
    J Med Virol. 2016 Mar 4. doi: 10.1002/jmv.24512.
    PubMed     Text format     Abstract available


  82. WEN J, Song C, Liu J, Chen J, et al
    Expression quantitative trait loci for TNFRSF10 influence both HBV infection and hepatocellular carcinoma development.
    J Med Virol. 2016;88:474-80.
    PubMed     Text format     Abstract available


  83. AKHTAR A, Khan AH, Sulaiman SA, Soo CT, et al
    HBV and HIV co-infection: Prevalence and clinical outcomes in tertiary care hospital Malaysia.
    J Med Virol. 2016;88:455-60.
    PubMed     Text format     Abstract available


    February 2016
  84. MAKHLOUF NA, Farghaly AM, Zaky S, Rashed HG, et al
    The efficacy of hepatitis B vaccination program in upper Egypt: Flow cytometry and the evaluation of long term immunogenicity.
    J Med Virol. 2016 Feb 22. doi: 10.1002/jmv.24506.
    PubMed     Text format     Abstract available


  85. LIU Y, Chen L, Zou Z, Zhu B, et al
    Hepatitis C virus infection induces elevation of CXCL10 in human brain microvascular endothelial cells.
    J Med Virol. 2016 Feb 19. doi: 10.1002/jmv.24504.
    PubMed     Text format     Abstract available


  86. AL-MUGHALES JA
    Co-infection assessment in HBV, HCV and HIV patients in western Saudi Arabia.
    J Med Virol. 2016 Feb 19. doi: 10.1002/jmv.24503.
    PubMed     Text format     Abstract available


  87. GEDEDZHA MP, Muzeze M, Burnett RJ, Amponsah-Dacosta E, et al
    Complete genome analysis of hepatitis B virus in human immunodeficiency virus infected and uninfected South Africans.
    J Med Virol. 2016 Feb 17. doi: 10.1002/jmv.24502.
    PubMed     Text format     Abstract available


  88. AROUCHA DC, Carmo RF, Vasconcelos LR, Lima RE, et al
    TNF-alpha and IL-10 polymorphisms increase the risk to hepatocellular carcinoma in HCV infected individuals.
    J Med Virol. 2016 Feb 17. doi: 10.1002/jmv.24501.
    PubMed     Text format     Abstract available


  89. LI M, Wang W, Jin R, Zhang T, et al
    Differential association of STAT3 and HK-II expression in hepatitis B virus- and hepatitis C virus-related hepatocellular carcinoma.
    J Med Virol. 2016 Feb 17. doi: 10.1002/jmv.24498.
    PubMed     Text format     Abstract available


  90. COSSABOOM CM, Heffron CL, Cao D, Yugo DM, et al
    Risk factors and sources of foodborne hepatitis E virus infection in the United States.
    J Med Virol. 2016 Feb 17. doi: 10.1002/jmv.24497.
    PubMed     Text format     Abstract available


  91. CHAUHAN R, Singh AK, Rooge S, Varshney A, et al
    Analysis of hepatitis B virus genotype changes in patients with chronic hepatitis B infection on tenofovir therapy.
    J Med Virol. 2016 Feb 9. doi: 10.1002/jmv.24489.
    PubMed     Text format     Abstract available


  92. BENSALEM A, Selmani K, Narjes H, Bencherifa N, et al
    Eastern region represents a worrying cluster of active hepatitis C in Algeria in 2012.
    J Med Virol. 2016 Feb 9. doi: 10.1002/jmv.24491.
    PubMed     Text format     Abstract available


    January 2016
  93. STEVENS K, Palmo T, Wangchuk T, Solomon S, et al
    Hepatitis B prevalence and treatment needs among Tibetan refugees residing in India.
    J Med Virol. 2016 Jan 29. doi: 10.1002/jmv.24488.
    PubMed     Text format     Abstract available


  94. D'ETTORRE G, Ceccarelli G, Serafino S, Giustini N, et al
    Dominant enrichment of phenotypically activated CD38 HLA-DR CD8 T cells, rather than CD38 HLA-DR CD4 T cells, in HIV/HCV coinfected patients on antiretroviral therapy.
    J Med Virol. 2016 Jan 14. doi: 10.1002/jmv.24475.
    PubMed     Text format     Abstract available


  95. BOKHARAEI-SALIM F, Keyvani H, Esghaei M, Zare-Karizi S, et al
    Prevalence of occult hepatitis C virus infection in the Iranian patients with human immunodeficiency virus infection.
    J Med Virol. 2016 Jan 14. doi: 10.1002/jmv.24474.
    PubMed     Text format     Abstract available


  96. TRIMBITAS RD, Fayssel N, Serghini FZ, Wakrim L, et al
    Molecular characterization of hepatitis C virus core region in Moroccan intravenous drug users.
    J Med Virol. 2016 Jan 11. doi: 10.1002/jmv.24470.
    PubMed     Text format     Abstract available


  97. ESMAT G, El Raziky M, Nabeel MM, Maher R, et al
    Seroprevalence of HCV among Cairo University students in Egypt.
    J Med Virol. 2016 Jan 11. doi: 10.1002/jmv.24469.
    PubMed     Text format     Abstract available


  98. WANG L, Zheng Y, Fu C, Huang S, et al
    Seroprevalence of hepatitis E virus infection among dogs in several developed cities in the Guangdong province of China.
    J Med Virol. 2016 Jan 7. doi: 10.1002/jmv.24468.
    PubMed     Text format     Abstract available


  99. ABDELRAHIM SS, Khiry RM, Esmail MA, Ragab M, et al
    Occult hepatitis C virus infection among Egyptian hemodialysis patients.
    J Med Virol. 2016 Jan 7. doi: 10.1002/jmv.24467.
    PubMed     Text format     Abstract available


  100. KATOONIZADEH A, Ghoroghi S, Sharafkhah M, Khoshnia M, et al
    Chronic hepatitis B infection is not associated with increased risk of vascular mortality while having an association with metabolic syndrome.
    J Med Virol. 2016 Jan 7. doi: 10.1002/jmv.24466.
    PubMed     Text format     Abstract available


  101. ARAIN A, Bourgeois S, de Galocsy C, Henrion J, et al
    Belgian experience with triple therapy with boceprevir and telaprevir in genotype 1 infected patients who inject drugs.
    J Med Virol. 2016;88:94-9.
    PubMed     Text format     Abstract available


  102. SUN HH, Zhou DF, Zhou JY
    The role of DCs in the immunopathogenesis of chronic HBV infection and the methods of inducing DCs maturation.
    J Med Virol. 2016;88:13-20.
    PubMed     Text format     Abstract available


    December 2015
  103. NDIAYE O, Gozlan J, Diop-Ndiaye H, Sall AS, et al
    Usefulness of Dried Blood Spots (DBS) to perform hepatitis C virus genotyping in drug users in Senegal.
    J Med Virol. 2015 Dec 24. doi: 10.1002/jmv.24460.
    PubMed     Text format     Abstract available


  104. LO G, Sow-Sall A, Diop-Ndiaye H, Mandiouba NC, et al
    Response to comments by Honge et al. on our paper titled "Prevalence of hepatitis B markers in Senegalese HIV-1 infected patients".
    J Med Virol. 2015 Dec 22. doi: 10.1002/jmv.24452.
    PubMed     Text format     Abstract available


  105. HONGE BL, Jespersen S, Medina C, Wejse C, et al
    Comment on Lo et al.: Prevalence of hepatitis B markers in Senegalese HIV-1 infected patients.
    J Med Virol. 2015 Dec 22. doi: 10.1002/jmv.24455.
    PubMed     Text format     Abstract available


  106. HUNDIE GB, Raj VS, Gebre Michael D, Pas SD, et al
    Molecular epidemiology and genetic diversity of hepatitis B virus in Ethiopia.
    J Med Virol. 2015 Dec 2. doi: 10.1002/jmv.24437.
    PubMed     Text format     Abstract available


    November 2015
  107. DE ARAUJO MARIZ C, Lopes EP, Ximenes RA, Lacerda HR, et al
    Serological markers of hepatitis B and C in patients with HIV/AIDS and active tuberculosis.
    J Med Virol. 2015 Nov 18. doi: 10.1002/jmv.24432.
    PubMed     Text format     Abstract available


  108. LEE S, Park JY, Kim DY, Kim BK, et al
    Prediction of virologic response to tenofovir mono-rescue therapy for multidrug resistant chronic hepatitis B.
    J Med Virol. 2015 Nov 5. doi: 10.1002/jmv.24427.
    PubMed     Text format     Abstract available


  109. WEIL C, Nwankwo C, Friedman M, Kenet G, et al
    Epidemiology of Hepatitis C Virus Infection in a Large Israeli Health Maintenance Organization.
    J Med Virol. 2015 Nov 5. doi: 10.1002/jmv.24426.
    PubMed     Text format     Abstract available


  110. WU Q, Xu C, Li J, Li L, et al
    Evolution and mutations of hepatitis B virus quasispecies in genotype B and C during vertical transmission.
    J Med Virol. 2015 Nov 4. doi: 10.1002/jmv.24424.
    PubMed     Text format     Abstract available


  111. CHO Y, Yu SJ, Cho EJ, Lee JH, et al
    High titers of anti-HBs prevent rituximab-related viral reactivation in resolved hepatitis B patient with non-Hodgkin's lymphoma.
    J Med Virol. 2015 Nov 4. doi: 10.1002/jmv.24423.
    PubMed     Text format     Abstract available


    October 2015
  112. ZHU JW, Liu FL, Mu D, Deng DY, et al
    Increased expression and dysregulated association of restriction factors and type I interferon in HIV, HCV mono- and co-infected patients.
    J Med Virol. 2015 Oct 31. doi: 10.1002/jmv.24419.
    PubMed     Text format     Abstract available


  113. FU J, Guo D, Gao D, Huang W, et al
    Clinical analysis of patients suffering from chronic hepatitis B superinfected with other hepadnaviruses.
    J Med Virol. 2015 Oct 28. doi: 10.1002/jmv.24417.
    PubMed     Text format     Abstract available


  114. MESQUITA JR, Abreu-Silva J, Sousa JC, Aguiar A, et al
    Evidence of autochthonous hepatitis E in a Portuguese pediatric cohort, 1992-1995.
    J Med Virol. 2015 Oct 23. doi: 10.1002/jmv.24414.
    PubMed     Text format     Abstract available


  115. FOUAD R, Abdo M, Gamal Eldeen H, Sabry D, et al
    Influence of delta virus infection on the virologic status in Egyptian patients with chronic hepatitis B virus genotype D.
    J Med Virol. 2015 Oct 21. doi: 10.1002/jmv.24412.
    PubMed     Text format     Abstract available


  116. SMITH DB, Paddy JO, Simmonds P
    The use of human sewage screening for community surveillance of hepatitis E virus in the UK.
    J Med Virol. 2015 Oct 13. doi: 10.1002/jmv.24403.
    PubMed     Text format     Abstract available


  117. ZABALETA A, Riezu-Boj JI, Larrea E, Villanueva L, et al
    Gene expression analysis during acute hepatitis C virus infection associates dendritic cell activation with viral clearance.
    J Med Virol. 2015 Oct 8. doi: 10.1002/jmv.24399.
    PubMed     Text format     Abstract available


  118. MOUSSA S, Brah S, Parola P, Gerolami R, et al
    Epidemiological, clinical, virological features of hepatitis B newly diagnosed in 2011 in Marseille University hospitals, southeastern France.
    J Med Virol. 2015 Oct 6. doi: 10.1002/jmv.24398.
    PubMed     Text format     Abstract available


    September 2015
  119. LEE HW, Lee SH, Lee MG, Ahn SH, et al
    The clinical implication of single nucleotide polymorphisms in deoxycytidine kinase in chronic hepatitis B patients treated with lamivudine.
    J Med Virol. 2015 Sep 24. doi: 10.1002/jmv.24393.
    PubMed     Text format     Abstract available


  120. SONG YJ, Park WJ, Park BJ, Kwak SW, et al
    Experimental evidence of hepatitis A virus infection in pigs.
    J Med Virol. 2015 Sep 18. doi: 10.1002/jmv.24386.
    PubMed     Text format     Abstract available


  121. TSATSRALT-OD B, Baasanjav N, Nyamkhuu D, Ohnishi H, et al
    Molecular analysis of hepatitis A virus strains obtained from patients with acute hepatitis A in Mongolia, 2004-2013.
    J Med Virol. 2015 Sep 15. doi: 10.1002/jmv.24380.
    PubMed     Text format     Abstract available


  122. APICA BS, Seremba E, Rule J, Yuan HJ, et al
    High prevalence of occult hepatitis B infection in an African urban population.
    J Med Virol. 2015 Sep 3. doi: 10.1002/jmv.24372.
    PubMed     Text format     Abstract available


    August 2015
  123. RACHIDA S, Matsapola PN, Wolfaardt M, Taylor MB, et al
    Genetic characterisation of a novel hepatitis a virus strain in irrigation water in south africa.
    J Med Virol. 2015 Aug 31. doi: 10.1002/jmv.24370.
    PubMed     Text format     Abstract available


  124. YIMNOI P, Posuwan N, Wanlapakorn N, Tangkijvanich P, et al
    A molecular epidemiological study of the hepatitis B virus in Thailand after 22 years of universal immunization.
    J Med Virol. 2015 Aug 31. doi: 10.1002/jmv.24368.
    PubMed     Text format     Abstract available


  125. BESHARAT S, Katoonizadeh A, Moossavi S, Darvishi Z, et al
    The possible impact of sortilin in reducing HBsAg expression in Chronic Hepatitis B.
    J Med Virol. 2015 Aug 31. doi: 10.1002/jmv.24367.
    PubMed     Text format     Abstract available


  126. CHENG Z, Zhi X, Sun G, Guo W, et al
    Sodium selenite suppresses hepatitis b virus transcription and replication in human hepatoma cell lines.
    J Med Virol. 2015 Aug 31. doi: 10.1002/jmv.24366.
    PubMed     Text format     Abstract available


  127. AKUTA N, Sezaki H, Suzuki F, Kawamura Y, et al
    Relationships between serum asunaprevir concentration and alanine aminotransferase elevation during daclatasvir plus asunaprevir for chronic HCV genotype 1b infection.
    J Med Virol. 2015 Aug 20. doi: 10.1002/jmv.24360.
    PubMed     Text format     Abstract available


  128. QI Y, Chen Q, Hao F, Wan Z, et al
    Subtype distribution of hepatitis C virus in Jiangsu, China.
    J Med Virol. 2015 Aug 19. doi: 10.1002/jmv.24356.
    PubMed     Text format     Abstract available


  129. NIKOLOPOULOS GK, Paraskevis D, Psichogiou M, Hatzakis A, et al
    HBV-DNA levels predict overall mortality in HIV/HBV coinfected individuals.
    J Med Virol. 2015 Aug 19. doi: 10.1002/jmv.24357.
    PubMed     Text format     Abstract available


  130. ESMAIL MA, Hassuna NA, Amr KS, Ghazawy ER, et al
    Polymorphisms at IL28B gene as predictors of viral relapse in genotype 4 Egyptian hepatitis C patients.
    J Med Virol. 2015 Aug 17. doi: 10.1002/jmv.24354.
    PubMed     Text format     Abstract available


  131. FABRIZI F, Dixit V, Martin P, Messa P, et al
    Hepatitis C virus increases the risk of kidney disease among HIV-positive patients: Systematic review and meta-analysis.
    J Med Virol. 2015 Aug 13. doi: 10.1002/jmv.24353.
    PubMed     Text format     Abstract available


  132. MATSUURA K, Isogawa M, Tanaka Y
    Host genetic variants influencing the clinical course of hepatitis B virus infection.
    J Med Virol. 2015 Aug 8. doi: 10.1002/jmv.24350.
    PubMed     Text format     Abstract available


  133. LO G, Sow-Sall A, Diop-Ndiaye H, Mandiouba NC, et al
    Prevalence of hepatitis B markers in Senegalese HIV-1 infected patients.
    J Med Virol. 2015 Aug 7. doi: 10.1002/jmv.24344.
    PubMed     Text format     Abstract available


  134. ZHONG L, Xi G, Zhang L, Liu S, et al
    The estimation of prevalence and risk factors of hepatitis B virus infection among blood donors in Chengdu, China.
    J Med Virol. 2015 Aug 4. doi: 10.1002/jmv.24339.
    PubMed     Text format     Abstract available


  135. FABRIZI F, Messa P, Martin P
    Reply to the letter by Pan Yanna et al. 'treatment of hepatitis C after kidney transplant: A pooled analysis of observational studies'.
    J Med Virol. 2015;87:1256-7.
    PubMed     Text format    


  136. PAN YN, Luo YJ, He S
    Comment on Fabrizi et al.: Treatment of hepatitis C after kidney transplant: A pooled analysis of observational studies.
    J Med Virol. 2015;87:1255.
    PubMed     Text format    


  137. LIU MH, Chen QY, Harrison TJ, Li GJ, et al
    The correlation between serum HBsAg levels and viral loads depends upon wild-type and mutated HBV sequences rather than the HBeAg/anti-HBe status.
    J Med Virol. 2015;87:1351-60.
    PubMed     Text format     Abstract available


    July 2015
  138. PASSOS-CASTILHO AM, de Sena A, Geraldo A, Spada C, et al
    High prevalence of hepatitis E virus antibodies among blood donors in Southern Brazil.
    J Med Virol. 2015 Jul 25. doi: 10.1002/jmv.24336.
    PubMed     Text format     Abstract available


  139. LEE SS, Jeong SH, Jang ES, Kim YS, et al
    Treatment rate and factors related to interferon-based treatment initiation for chronic hepatitis C in South Korea.
    J Med Virol. 2015 Jul 25. doi: 10.1002/jmv.24335.
    PubMed     Text format     Abstract available


  140. MATSUURA K, Tanaka Y
    Host genetic variants influencing the clinical course of hepatitis C virus infection.
    J Med Virol. 2015 Jul 25. doi: 10.1002/jmv.24334.
    PubMed     Text format     Abstract available


  141. PARK JH, Ahn SJ, Cho HJ, Kim SS, et al
    Clinical course of partial virological responders under prolonged entecavir monotherapy in patients with chronic hepatitis B.
    J Med Virol. 2015 Jul 14. doi: 10.1002/jmv.24330.
    PubMed     Text format     Abstract available


  142. WANG Q, Luan W, Warren L, Fiel MI, et al
    Serum hepatitis B surface antigen correlates with tissue covalently closed circular DNA in patients with hepatitis B-associated hepatocellular carcinoma.
    J Med Virol. 2015 Jul 14. doi: 10.1002/jmv.24326.
    PubMed     Text format     Abstract available


  143. BARTOLOME J, Castillo I, Quiroga JA, Carreno V, et al
    Interleukin-28B polymorphisms and interferon gamma inducible protein-10 serum levels in seronegative occult hepatitis C virus infection.
    J Med Virol. 2015 Jul 3. doi: 10.1002/jmv.24322.
    PubMed     Text format     Abstract available


  144. TSATSRALT-OD B, Baasanjav N, Nyamkhuu D, Ohnishi H, et al
    Prevalence of hepatitis viruses in patients with acute hepatitis and characterization of the detected genotype 4 hepatitis E virus sequences in Mongolia.
    J Med Virol. 2015 Jul 3. doi: 10.1002/jmv.24319.
    PubMed     Text format     Abstract available


  145. HANAFY AS, Farag AA, Hassanin HM, Hassaneen AM, et al
    Recombinant HBV vaccine enhances the rate of sustained virological response when early initiated after anti-HCV combination therapy.
    J Med Virol. 2015 Jul 3. doi: 10.1002/jmv.24317.
    PubMed     Text format     Abstract available


    June 2015
  146. INOUE J, Kondo Y, Umetsu T, Yamamoto T, et al
    Shifting hepatitis B virus genotypes of acute hepatitis B patients in northeast Japan.
    J Med Virol. 2015 Jun 25. doi: 10.1002/jmv.24309.
    PubMed     Text format     Abstract available


  147. HAN ZG, Qie ZH, Qiao WZ
    HBsAg spontaneous seroclearance in a cohort of HBeAg-seronegative patients with chronic hepatitis B virus infection.
    J Med Virol. 2015 Jun 25. doi: 10.1002/jmv.24311.
    PubMed     Text format     Abstract available


  148. CHEN S, Li S, Chen L
    Interferon-inducible protein 6-16 (IFI-6-16, ISG16) promotes hepatitis C virus replication in vitro.
    J Med Virol. 2015 Jun 23. doi: 10.1002/jmv.24302.
    PubMed     Text format     Abstract available


  149. AZIZ H, Raza A, Irfan J
    Optimum predictors of therapeutic outcome in HCV patients in Pakistan.
    J Med Virol. 2015 Jun 23. doi: 10.1002/jmv.24305.
    PubMed     Text format     Abstract available


  150. ABUODEH RO, Al-Absi E, Ali NH, Khalili M, et al
    Detection and Phylogenetic Analysis of Human Pegivirus (GBV-C) among Blood Donors and Patients Infected with Hepatitis B Virus (HBV) in Qatar.
    J Med Virol. 2015 Jun 9. doi: 10.1002/jmv.24289.
    PubMed     Text format     Abstract available


  151. STROFFOLINI T, Esvan R, Biliotti E, Sagnelli E, et al
    Gender differences in chronic HBsAg carriers in Italy: Evidence for the independent role of male sex in severity of liver disease.
    J Med Virol. 2015 Jun 2. doi: 10.1002/jmv.24243.
    PubMed     Text format     Abstract available


    May 2015
  152. SU F, Dai J, Yang S, Jiang X, et al
    Prevalence and types of drug-resistant variants in Chinese patients with acute hepatitis B.
    J Med Virol. 2015 May 29. doi: 10.1002/jmv.24006.
    PubMed     Text format     Abstract available


  153. SUN W, Li Q, Zhu D, Feng J, et al
    Enhancement of immune response to a hepatitis C virus E2 DNA vaccine by an immunoglobulin Fc fusion tag.
    J Med Virol. 2015 May 25. doi: 10.1002/jmv.24277.
    PubMed     Text format     Abstract available


  154. IWASAKI Y, Okamoto RI, Ishii Y, Araki Y, et al
    Randomized trial of low-dose peginterferon alpha-2b plus low and escalating doses of ribavirin in older patients with chronic hepatitis C with high viral load genotype 1.
    J Med Virol. 2015 May 22. doi: 10.1002/jmv.24276.
    PubMed     Text format     Abstract available


  155. ZHANG YY, Hu KQ
    Rethinking the pathogenesis of hepatitis B virus (HBV) infection.
    J Med Virol. 2015 May 18. doi: 10.1002/jmv.24270.
    PubMed     Text format     Abstract available


  156. GARCIA COMAS L, Ordobas Gavin M, Sanz Moreno JC, Ramos Blazquez B, et al
    Prevalence of hepatitis C antibodies in the population aged 16-80 years in the Community of Madrid 2008-2009.
    J Med Virol. 2015 May 18. doi: 10.1002/jmv.24219.
    PubMed     Text format     Abstract available


  157. GROTTO RM, Picelli N, de Souza LD, Silva GF, et al
    Human Platelet Polymorphism can be a genetic marker associated with HIV/HCV coinfection.
    J Med Virol. 2015 May 14. doi: 10.1002/jmv.24233.
    PubMed     Text format     Abstract available


  158. OLMEDO DB, Cader SA, Porto LC
    IFN-lambda gene polymorphisms as predictive factors in chronic hepatitis C treatment-naive patients without access to protease inhibitors.
    J Med Virol. 2015 May 12. doi: 10.1002/jmv.24227.
    PubMed     Text format     Abstract available


  159. SAMIMI-RAD K, Sadeghi F, Amirzargar A, Eshraghian MR, et al
    Association of HLA class II alleles with hepatitis C virus clearance and persistence in thalassemia patients from Iran.
    J Med Virol. 2015 May 12. doi: 10.1002/jmv.24211.
    PubMed     Text format     Abstract available


  160. ZENG DW, Dong J, Zhang JM, Zhu YY, et al
    HBeAg-negative chronic hepatitis patients should be monitored more strictly: A cross-sectional retrospective study on antiviral treatment-naive patients.
    J Med Virol. 2015 May 12. doi: 10.1002/jmv.24217.
    PubMed     Text format     Abstract available


  161. POLITOU M, Boti S, Androutsakos T, Valsami S, et al
    Seroprevalence of hepatitis E in HIV infected patients in Greece.
    J Med Virol. 2015 May 12. doi: 10.1002/jmv.24214.
    PubMed     Text format     Abstract available


  162. ZHANG Z, Zhang L, Dai Y, Jin L, et al
    Occult hepatitis B virus infection among people with a family history of chronic hepatitis B virus infection.
    J Med Virol. 2015 May 11. doi: 10.1002/jmv.24245.
    PubMed     Text format     Abstract available


  163. ARAI T, Atsukawa M, Tsubota A, Kondo C, et al
    Vitamin D-related gene polymorphisms do not influence the outcome and serum vitamin D level in pegylated interferon/ribavirin therapy combined with protease inhibitor for patients with genotype 1b chronic hepatitis C.
    J Med Virol. 2015 May 11. doi: 10.1002/jmv.24244.
    PubMed     Text format     Abstract available


  164. HAJJI H, Aherfi S, Motte A, Ravaux I, et al
    Diversity of 1,213 hepatitis C virus NS3 protease sequences from a clinical virology laboratory database in Marseille University Hospitals, Southeastern France.
    J Med Virol. 2015 May 8. doi: 10.1002/jmv.24261.
    PubMed     Text format     Abstract available


  165. AVELLON A, Morago L, Garcia-Galera M, Munoz M, et al
    Comparative sensitivity of commercial tests for hepatitis E genotype 3 virus antibody detection.
    J Med Virol. 2015 May 8. doi: 10.1002/jmv.24251.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: